nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—Venlafaxine—ABCB1—esophageal cancer	0.00261	0.695	CrCbGaD
Tramadol—Dextromethorphan—ABCB1—esophageal cancer	0.00114	0.305	CrCbGaD
Tramadol—Cardiac disorder—Cisplatin—esophageal cancer	0.0011	0.00152	CcSEcCtD
Tramadol—Abdominal distension—Capecitabine—esophageal cancer	0.0011	0.00152	CcSEcCtD
Tramadol—Asthma—Capecitabine—esophageal cancer	0.00109	0.00151	CcSEcCtD
Tramadol—Influenza—Capecitabine—esophageal cancer	0.00109	0.00151	CcSEcCtD
Tramadol—Dysphagia—Capecitabine—esophageal cancer	0.00109	0.00151	CcSEcCtD
Tramadol—Diabetes mellitus—Methotrexate—esophageal cancer	0.00108	0.0015	CcSEcCtD
Tramadol—Bronchospasm—Capecitabine—esophageal cancer	0.00107	0.00149	CcSEcCtD
Tramadol—Photosensitivity—Methotrexate—esophageal cancer	0.00107	0.00148	CcSEcCtD
Tramadol—Polyuria—Methotrexate—esophageal cancer	0.00107	0.00148	CcSEcCtD
Tramadol—Immune system disorder—Cisplatin—esophageal cancer	0.00107	0.00148	CcSEcCtD
Tramadol—Mediastinal disorder—Cisplatin—esophageal cancer	0.00107	0.00148	CcSEcCtD
Tramadol—Sweating increased—Capecitabine—esophageal cancer	0.00106	0.00147	CcSEcCtD
Tramadol—Angina pectoris—Capecitabine—esophageal cancer	0.00106	0.00147	CcSEcCtD
Tramadol—Arrhythmia—Cisplatin—esophageal cancer	0.00106	0.00147	CcSEcCtD
Tramadol—Bronchitis—Capecitabine—esophageal cancer	0.00105	0.00145	CcSEcCtD
Tramadol—Abdominal discomfort—Capecitabine—esophageal cancer	0.00104	0.00145	CcSEcCtD
Tramadol—Hepatic failure—Methotrexate—esophageal cancer	0.00104	0.00145	CcSEcCtD
Tramadol—Malnutrition—Cisplatin—esophageal cancer	0.00103	0.00143	CcSEcCtD
Tramadol—Erythema—Cisplatin—esophageal cancer	0.00103	0.00143	CcSEcCtD
Tramadol—Dysuria—Capecitabine—esophageal cancer	0.00102	0.00141	CcSEcCtD
Tramadol—Flatulence—Cisplatin—esophageal cancer	0.00101	0.00141	CcSEcCtD
Tramadol—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00101	0.00141	CcSEcCtD
Tramadol—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000995	0.00138	CcSEcCtD
Tramadol—Visual disturbance—Methotrexate—esophageal cancer	0.00099	0.00138	CcSEcCtD
Tramadol—Muscle spasms—Cisplatin—esophageal cancer	0.00099	0.00137	CcSEcCtD
Tramadol—Weight decreased—Capecitabine—esophageal cancer	0.000986	0.00137	CcSEcCtD
Tramadol—Hyperglycaemia—Capecitabine—esophageal cancer	0.000983	0.00136	CcSEcCtD
Tramadol—Pneumonia—Capecitabine—esophageal cancer	0.000977	0.00136	CcSEcCtD
Tramadol—Infestation NOS—Capecitabine—esophageal cancer	0.000972	0.00135	CcSEcCtD
Tramadol—Infestation—Capecitabine—esophageal cancer	0.000972	0.00135	CcSEcCtD
Tramadol—Vision blurred—Cisplatin—esophageal cancer	0.000971	0.00135	CcSEcCtD
Tramadol—Depression—Capecitabine—esophageal cancer	0.000969	0.00135	CcSEcCtD
Tramadol—Tremor—Cisplatin—esophageal cancer	0.000965	0.00134	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000963	0.00134	CcSEcCtD
Tramadol—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000958	0.00133	CcSEcCtD
Tramadol—Lethargy—Methotrexate—esophageal cancer	0.000958	0.00133	CcSEcCtD
Tramadol—Ill-defined disorder—Cisplatin—esophageal cancer	0.000956	0.00133	CcSEcCtD
Tramadol—Renal failure—Capecitabine—esophageal cancer	0.000955	0.00133	CcSEcCtD
Tramadol—Myocardial infarction—Capecitabine—esophageal cancer	0.000952	0.00132	CcSEcCtD
Tramadol—Anaemia—Cisplatin—esophageal cancer	0.000952	0.00132	CcSEcCtD
Tramadol—Stomatitis—Capecitabine—esophageal cancer	0.000947	0.00131	CcSEcCtD
Tramadol—Urinary tract infection—Capecitabine—esophageal cancer	0.000944	0.00131	CcSEcCtD
Tramadol—Conjunctivitis—Capecitabine—esophageal cancer	0.000944	0.00131	CcSEcCtD
Tramadol—Osteoarthritis—Methotrexate—esophageal cancer	0.000939	0.0013	CcSEcCtD
Tramadol—Malaise—Cisplatin—esophageal cancer	0.000929	0.00129	CcSEcCtD
Tramadol—Haematuria—Capecitabine—esophageal cancer	0.000926	0.00129	CcSEcCtD
Tramadol—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000919	0.00128	CcSEcCtD
Tramadol—Epistaxis—Capecitabine—esophageal cancer	0.000916	0.00127	CcSEcCtD
Tramadol—Irritability—Methotrexate—esophageal cancer	0.000896	0.00124	CcSEcCtD
Tramadol—Convulsion—Cisplatin—esophageal cancer	0.000892	0.00124	CcSEcCtD
Tramadol—Mood swings—Methotrexate—esophageal cancer	0.000889	0.00123	CcSEcCtD
Tramadol—Bradycardia—Capecitabine—esophageal cancer	0.000888	0.00123	CcSEcCtD
Tramadol—Ataxia—Methotrexate—esophageal cancer	0.000882	0.00123	CcSEcCtD
Tramadol—Myalgia—Cisplatin—esophageal cancer	0.000877	0.00122	CcSEcCtD
Tramadol—Haemoglobin—Capecitabine—esophageal cancer	0.000877	0.00122	CcSEcCtD
Tramadol—Rhinitis—Capecitabine—esophageal cancer	0.000874	0.00121	CcSEcCtD
Tramadol—Anxiety—Cisplatin—esophageal cancer	0.000874	0.00121	CcSEcCtD
Tramadol—Hepatitis—Capecitabine—esophageal cancer	0.000872	0.00121	CcSEcCtD
Tramadol—Haemorrhage—Capecitabine—esophageal cancer	0.000872	0.00121	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000871	0.00121	CcSEcCtD
Tramadol—Hypoaesthesia—Capecitabine—esophageal cancer	0.000868	0.0012	CcSEcCtD
Tramadol—Liver function test abnormal—Methotrexate—esophageal cancer	0.000866	0.0012	CcSEcCtD
Tramadol—Discomfort—Cisplatin—esophageal cancer	0.000866	0.0012	CcSEcCtD
Tramadol—Pharyngitis—Capecitabine—esophageal cancer	0.000866	0.0012	CcSEcCtD
Tramadol—Urinary tract disorder—Capecitabine—esophageal cancer	0.000861	0.0012	CcSEcCtD
Tramadol—Oedema peripheral—Capecitabine—esophageal cancer	0.000859	0.00119	CcSEcCtD
Tramadol—Connective tissue disorder—Capecitabine—esophageal cancer	0.000857	0.00119	CcSEcCtD
Tramadol—Urethral disorder—Capecitabine—esophageal cancer	0.000855	0.00119	CcSEcCtD
Tramadol—Breast disorder—Methotrexate—esophageal cancer	0.000848	0.00118	CcSEcCtD
Tramadol—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000845	0.00117	CcSEcCtD
Tramadol—Anaphylactic shock—Cisplatin—esophageal cancer	0.000841	0.00117	CcSEcCtD
Tramadol—Visual impairment—Capecitabine—esophageal cancer	0.000841	0.00117	CcSEcCtD
Tramadol—Infection—Cisplatin—esophageal cancer	0.000835	0.00116	CcSEcCtD
Tramadol—Erythema multiforme—Capecitabine—esophageal cancer	0.000825	0.00114	CcSEcCtD
Tramadol—Nervous system disorder—Cisplatin—esophageal cancer	0.000824	0.00114	CcSEcCtD
Tramadol—Thrombocytopenia—Cisplatin—esophageal cancer	0.000823	0.00114	CcSEcCtD
Tramadol—Tachycardia—Cisplatin—esophageal cancer	0.00082	0.00114	CcSEcCtD
Tramadol—Skin disorder—Cisplatin—esophageal cancer	0.000817	0.00113	CcSEcCtD
Tramadol—Eye disorder—Capecitabine—esophageal cancer	0.000815	0.00113	CcSEcCtD
Tramadol—Tinnitus—Capecitabine—esophageal cancer	0.000813	0.00113	CcSEcCtD
Tramadol—Hyperhidrosis—Cisplatin—esophageal cancer	0.000813	0.00113	CcSEcCtD
Tramadol—Asthma—Methotrexate—esophageal cancer	0.000811	0.00113	CcSEcCtD
Tramadol—Cardiac disorder—Capecitabine—esophageal cancer	0.000809	0.00112	CcSEcCtD
Tramadol—Flushing—Capecitabine—esophageal cancer	0.000809	0.00112	CcSEcCtD
Tramadol—Anorexia—Cisplatin—esophageal cancer	0.000801	0.00111	CcSEcCtD
Tramadol—Pancreatitis—Methotrexate—esophageal cancer	0.000795	0.0011	CcSEcCtD
Tramadol—Angiopathy—Capecitabine—esophageal cancer	0.000791	0.0011	CcSEcCtD
Tramadol—Immune system disorder—Capecitabine—esophageal cancer	0.000788	0.00109	CcSEcCtD
Tramadol—Mediastinal disorder—Capecitabine—esophageal cancer	0.000786	0.00109	CcSEcCtD
Tramadol—Hypotension—Cisplatin—esophageal cancer	0.000785	0.00109	CcSEcCtD
Tramadol—Chills—Capecitabine—esophageal cancer	0.000783	0.00109	CcSEcCtD
Tramadol—Arrhythmia—Capecitabine—esophageal cancer	0.000779	0.00108	CcSEcCtD
Tramadol—Abdominal discomfort—Methotrexate—esophageal cancer	0.000778	0.00108	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000766	0.00106	CcSEcCtD
Tramadol—Mental disorder—Capecitabine—esophageal cancer	0.000764	0.00106	CcSEcCtD
Tramadol—Erythema—Capecitabine—esophageal cancer	0.000759	0.00105	CcSEcCtD
Tramadol—Malnutrition—Capecitabine—esophageal cancer	0.000759	0.00105	CcSEcCtD
Tramadol—Dysuria—Methotrexate—esophageal cancer	0.000759	0.00105	CcSEcCtD
Tramadol—Paraesthesia—Cisplatin—esophageal cancer	0.000755	0.00105	CcSEcCtD
Tramadol—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000754	0.00105	CcSEcCtD
Tramadol—Dyspnoea—Cisplatin—esophageal cancer	0.000749	0.00104	CcSEcCtD
Tramadol—Flatulence—Capecitabine—esophageal cancer	0.000748	0.00104	CcSEcCtD
Tramadol—Erectile dysfunction—Methotrexate—esophageal cancer	0.000747	0.00104	CcSEcCtD
Tramadol—Dysgeusia—Capecitabine—esophageal cancer	0.000744	0.00103	CcSEcCtD
Tramadol—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00074	0.00103	CcSEcCtD
Tramadol—Back pain—Capecitabine—esophageal cancer	0.000734	0.00102	CcSEcCtD
Tramadol—Decreased appetite—Cisplatin—esophageal cancer	0.000731	0.00101	CcSEcCtD
Tramadol—Muscle spasms—Capecitabine—esophageal cancer	0.00073	0.00101	CcSEcCtD
Tramadol—Pneumonia—Methotrexate—esophageal cancer	0.000727	0.00101	CcSEcCtD
Tramadol—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000726	0.00101	CcSEcCtD
Tramadol—Infestation NOS—Methotrexate—esophageal cancer	0.000723	0.001	CcSEcCtD
Tramadol—Infestation—Methotrexate—esophageal cancer	0.000723	0.001	CcSEcCtD
Tramadol—Depression—Methotrexate—esophageal cancer	0.000721	0.001	CcSEcCtD
Tramadol—Pain—Cisplatin—esophageal cancer	0.000719	0.000998	CcSEcCtD
Tramadol—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000717	0.000996	CcSEcCtD
Tramadol—Vision blurred—Capecitabine—esophageal cancer	0.000716	0.000993	CcSEcCtD
Tramadol—Tremor—Capecitabine—esophageal cancer	0.000711	0.000988	CcSEcCtD
Tramadol—Renal failure—Methotrexate—esophageal cancer	0.000711	0.000987	CcSEcCtD
Tramadol—Stomatitis—Methotrexate—esophageal cancer	0.000705	0.000979	CcSEcCtD
Tramadol—Ill-defined disorder—Capecitabine—esophageal cancer	0.000704	0.000978	CcSEcCtD
Tramadol—Conjunctivitis—Methotrexate—esophageal cancer	0.000703	0.000976	CcSEcCtD
Tramadol—Anaemia—Capecitabine—esophageal cancer	0.000702	0.000974	CcSEcCtD
Tramadol—Sweating—Methotrexate—esophageal cancer	0.000693	0.000963	CcSEcCtD
Tramadol—Feeling abnormal—Cisplatin—esophageal cancer	0.000693	0.000962	CcSEcCtD
Tramadol—Haematuria—Methotrexate—esophageal cancer	0.00069	0.000957	CcSEcCtD
Tramadol—Malaise—Capecitabine—esophageal cancer	0.000685	0.000951	CcSEcCtD
Tramadol—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000684	0.00095	CcSEcCtD
Tramadol—Epistaxis—Methotrexate—esophageal cancer	0.000682	0.000947	CcSEcCtD
Tramadol—Vertigo—Capecitabine—esophageal cancer	0.000682	0.000947	CcSEcCtD
Tramadol—Syncope—Capecitabine—esophageal cancer	0.000681	0.000945	CcSEcCtD
Tramadol—Palpitations—Capecitabine—esophageal cancer	0.000671	0.000932	CcSEcCtD
Tramadol—Loss of consciousness—Capecitabine—esophageal cancer	0.000667	0.000926	CcSEcCtD
Tramadol—Body temperature increased—Cisplatin—esophageal cancer	0.000665	0.000923	CcSEcCtD
Tramadol—Cough—Capecitabine—esophageal cancer	0.000663	0.00092	CcSEcCtD
Tramadol—Hypertension—Capecitabine—esophageal cancer	0.000656	0.00091	CcSEcCtD
Tramadol—Haemoglobin—Methotrexate—esophageal cancer	0.000653	0.000906	CcSEcCtD
Tramadol—Haemorrhage—Methotrexate—esophageal cancer	0.000649	0.000901	CcSEcCtD
Tramadol—Hepatitis—Methotrexate—esophageal cancer	0.000649	0.000901	CcSEcCtD
Tramadol—Arthralgia—Capecitabine—esophageal cancer	0.000646	0.000897	CcSEcCtD
Tramadol—Chest pain—Capecitabine—esophageal cancer	0.000646	0.000897	CcSEcCtD
Tramadol—Myalgia—Capecitabine—esophageal cancer	0.000646	0.000897	CcSEcCtD
Tramadol—Pharyngitis—Methotrexate—esophageal cancer	0.000644	0.000895	CcSEcCtD
Tramadol—Anxiety—Capecitabine—esophageal cancer	0.000644	0.000894	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000642	0.000891	CcSEcCtD
Tramadol—Urinary tract disorder—Methotrexate—esophageal cancer	0.000641	0.00089	CcSEcCtD
Tramadol—Discomfort—Capecitabine—esophageal cancer	0.000639	0.000887	CcSEcCtD
Tramadol—Urethral disorder—Methotrexate—esophageal cancer	0.000636	0.000884	CcSEcCtD
Tramadol—Dry mouth—Capecitabine—esophageal cancer	0.000632	0.000878	CcSEcCtD
Tramadol—Visual impairment—Methotrexate—esophageal cancer	0.000626	0.000869	CcSEcCtD
Tramadol—Confusional state—Capecitabine—esophageal cancer	0.000625	0.000867	CcSEcCtD
Tramadol—Hypersensitivity—Cisplatin—esophageal cancer	0.000619	0.00086	CcSEcCtD
Tramadol—Infection—Capecitabine—esophageal cancer	0.000616	0.000855	CcSEcCtD
Tramadol—Erythema multiforme—Methotrexate—esophageal cancer	0.000614	0.000852	CcSEcCtD
Tramadol—Shock—Capecitabine—esophageal cancer	0.00061	0.000846	CcSEcCtD
Tramadol—Nervous system disorder—Capecitabine—esophageal cancer	0.000608	0.000844	CcSEcCtD
Tramadol—Eye disorder—Methotrexate—esophageal cancer	0.000607	0.000842	CcSEcCtD
Tramadol—Thrombocytopenia—Capecitabine—esophageal cancer	0.000607	0.000842	CcSEcCtD
Tramadol—Tinnitus—Methotrexate—esophageal cancer	0.000605	0.00084	CcSEcCtD
Tramadol—Tachycardia—Capecitabine—esophageal cancer	0.000605	0.00084	CcSEcCtD
Tramadol—Asthenia—Cisplatin—esophageal cancer	0.000603	0.000837	CcSEcCtD
Tramadol—Cardiac disorder—Methotrexate—esophageal cancer	0.000603	0.000837	CcSEcCtD
Tramadol—Skin disorder—Capecitabine—esophageal cancer	0.000602	0.000836	CcSEcCtD
Tramadol—Hyperhidrosis—Capecitabine—esophageal cancer	0.000599	0.000832	CcSEcCtD
Tramadol—Anorexia—Capecitabine—esophageal cancer	0.000591	0.00082	CcSEcCtD
Tramadol—Angiopathy—Methotrexate—esophageal cancer	0.000589	0.000818	CcSEcCtD
Tramadol—Immune system disorder—Methotrexate—esophageal cancer	0.000586	0.000814	CcSEcCtD
Tramadol—Mediastinal disorder—Methotrexate—esophageal cancer	0.000585	0.000812	CcSEcCtD
Tramadol—Chills—Methotrexate—esophageal cancer	0.000583	0.000809	CcSEcCtD
Tramadol—Hypotension—Capecitabine—esophageal cancer	0.000579	0.000804	CcSEcCtD
Tramadol—Diarrhoea—Cisplatin—esophageal cancer	0.000575	0.000799	CcSEcCtD
Tramadol—Mental disorder—Methotrexate—esophageal cancer	0.000569	0.00079	CcSEcCtD
Tramadol—Malnutrition—Methotrexate—esophageal cancer	0.000565	0.000785	CcSEcCtD
Tramadol—Erythema—Methotrexate—esophageal cancer	0.000565	0.000785	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000565	0.000784	CcSEcCtD
Tramadol—Insomnia—Capecitabine—esophageal cancer	0.00056	0.000778	CcSEcCtD
Tramadol—Paraesthesia—Capecitabine—esophageal cancer	0.000556	0.000773	CcSEcCtD
Tramadol—Dysgeusia—Methotrexate—esophageal cancer	0.000553	0.000768	CcSEcCtD
Tramadol—Dyspnoea—Capecitabine—esophageal cancer	0.000552	0.000767	CcSEcCtD
Tramadol—Back pain—Methotrexate—esophageal cancer	0.000547	0.000759	CcSEcCtD
Tramadol—Dyspepsia—Capecitabine—esophageal cancer	0.000545	0.000757	CcSEcCtD
Tramadol—Decreased appetite—Capecitabine—esophageal cancer	0.000539	0.000748	CcSEcCtD
Tramadol—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000535	0.000743	CcSEcCtD
Tramadol—Vomiting—Cisplatin—esophageal cancer	0.000534	0.000742	CcSEcCtD
Tramadol—Fatigue—Capecitabine—esophageal cancer	0.000534	0.000742	CcSEcCtD
Tramadol—Vision blurred—Methotrexate—esophageal cancer	0.000533	0.00074	CcSEcCtD
Tramadol—Rash—Cisplatin—esophageal cancer	0.00053	0.000736	CcSEcCtD
Tramadol—Constipation—Capecitabine—esophageal cancer	0.00053	0.000736	CcSEcCtD
Tramadol—Pain—Capecitabine—esophageal cancer	0.00053	0.000736	CcSEcCtD
Tramadol—Dermatitis—Cisplatin—esophageal cancer	0.00053	0.000735	CcSEcCtD
Tramadol—Ill-defined disorder—Methotrexate—esophageal cancer	0.000524	0.000728	CcSEcCtD
Tramadol—Anaemia—Methotrexate—esophageal cancer	0.000522	0.000725	CcSEcCtD
Tramadol—Feeling abnormal—Capecitabine—esophageal cancer	0.000511	0.000709	CcSEcCtD
Tramadol—Malaise—Methotrexate—esophageal cancer	0.00051	0.000708	CcSEcCtD
Tramadol—Vertigo—Methotrexate—esophageal cancer	0.000508	0.000705	CcSEcCtD
Tramadol—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000507	0.000703	CcSEcCtD
Tramadol—Nausea—Cisplatin—esophageal cancer	0.000499	0.000693	CcSEcCtD
Tramadol—Cough—Methotrexate—esophageal cancer	0.000493	0.000685	CcSEcCtD
Tramadol—Urticaria—Capecitabine—esophageal cancer	0.000492	0.000683	CcSEcCtD
Tramadol—Abdominal pain—Capecitabine—esophageal cancer	0.00049	0.00068	CcSEcCtD
Tramadol—Body temperature increased—Capecitabine—esophageal cancer	0.00049	0.00068	CcSEcCtD
Tramadol—Convulsion—Methotrexate—esophageal cancer	0.00049	0.00068	CcSEcCtD
Tramadol—Arthralgia—Methotrexate—esophageal cancer	0.000481	0.000668	CcSEcCtD
Tramadol—Myalgia—Methotrexate—esophageal cancer	0.000481	0.000668	CcSEcCtD
Tramadol—Chest pain—Methotrexate—esophageal cancer	0.000481	0.000668	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000478	0.000663	CcSEcCtD
Tramadol—Discomfort—Methotrexate—esophageal cancer	0.000475	0.00066	CcSEcCtD
Tramadol—Confusional state—Methotrexate—esophageal cancer	0.000465	0.000646	CcSEcCtD
Tramadol—Anaphylactic shock—Methotrexate—esophageal cancer	0.000461	0.00064	CcSEcCtD
Tramadol—Infection—Methotrexate—esophageal cancer	0.000458	0.000636	CcSEcCtD
Tramadol—Hypersensitivity—Capecitabine—esophageal cancer	0.000457	0.000634	CcSEcCtD
Tramadol—Nervous system disorder—Methotrexate—esophageal cancer	0.000452	0.000628	CcSEcCtD
Tramadol—Thrombocytopenia—Methotrexate—esophageal cancer	0.000452	0.000627	CcSEcCtD
Tramadol—Skin disorder—Methotrexate—esophageal cancer	0.000448	0.000622	CcSEcCtD
Tramadol—Hyperhidrosis—Methotrexate—esophageal cancer	0.000446	0.000619	CcSEcCtD
Tramadol—Asthenia—Capecitabine—esophageal cancer	0.000445	0.000617	CcSEcCtD
Tramadol—Anorexia—Methotrexate—esophageal cancer	0.00044	0.00061	CcSEcCtD
Tramadol—Pruritus—Capecitabine—esophageal cancer	0.000438	0.000609	CcSEcCtD
Tramadol—Hypotension—Methotrexate—esophageal cancer	0.000431	0.000598	CcSEcCtD
Tramadol—Diarrhoea—Capecitabine—esophageal cancer	0.000424	0.000589	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00042	0.000583	CcSEcCtD
Tramadol—Insomnia—Methotrexate—esophageal cancer	0.000417	0.000579	CcSEcCtD
Tramadol—Paraesthesia—Methotrexate—esophageal cancer	0.000414	0.000575	CcSEcCtD
Tramadol—Dyspnoea—Methotrexate—esophageal cancer	0.000411	0.000571	CcSEcCtD
Tramadol—Somnolence—Methotrexate—esophageal cancer	0.00041	0.000569	CcSEcCtD
Tramadol—Dizziness—Capecitabine—esophageal cancer	0.00041	0.000569	CcSEcCtD
Tramadol—Dyspepsia—Methotrexate—esophageal cancer	0.000406	0.000564	CcSEcCtD
Tramadol—Decreased appetite—Methotrexate—esophageal cancer	0.000401	0.000557	CcSEcCtD
Tramadol—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000398	0.000553	CcSEcCtD
Tramadol—Fatigue—Methotrexate—esophageal cancer	0.000398	0.000552	CcSEcCtD
Tramadol—Pain—Methotrexate—esophageal cancer	0.000394	0.000548	CcSEcCtD
Tramadol—Vomiting—Capecitabine—esophageal cancer	0.000394	0.000547	CcSEcCtD
Tramadol—Rash—Capecitabine—esophageal cancer	0.000391	0.000542	CcSEcCtD
Tramadol—Dermatitis—Capecitabine—esophageal cancer	0.00039	0.000542	CcSEcCtD
Tramadol—Headache—Capecitabine—esophageal cancer	0.000388	0.000539	CcSEcCtD
Tramadol—Feeling abnormal—Methotrexate—esophageal cancer	0.00038	0.000528	CcSEcCtD
Tramadol—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000377	0.000524	CcSEcCtD
Tramadol—Nausea—Capecitabine—esophageal cancer	0.000368	0.000511	CcSEcCtD
Tramadol—Urticaria—Methotrexate—esophageal cancer	0.000366	0.000509	CcSEcCtD
Tramadol—Abdominal pain—Methotrexate—esophageal cancer	0.000365	0.000506	CcSEcCtD
Tramadol—Body temperature increased—Methotrexate—esophageal cancer	0.000365	0.000506	CcSEcCtD
Tramadol—Hypersensitivity—Methotrexate—esophageal cancer	0.00034	0.000472	CcSEcCtD
Tramadol—Asthenia—Methotrexate—esophageal cancer	0.000331	0.000459	CcSEcCtD
Tramadol—Pruritus—Methotrexate—esophageal cancer	0.000326	0.000453	CcSEcCtD
Tramadol—Diarrhoea—Methotrexate—esophageal cancer	0.000316	0.000438	CcSEcCtD
Tramadol—Dizziness—Methotrexate—esophageal cancer	0.000305	0.000424	CcSEcCtD
Tramadol—Vomiting—Methotrexate—esophageal cancer	0.000293	0.000407	CcSEcCtD
Tramadol—Rash—Methotrexate—esophageal cancer	0.000291	0.000404	CcSEcCtD
Tramadol—Dermatitis—Methotrexate—esophageal cancer	0.000291	0.000403	CcSEcCtD
Tramadol—Headache—Methotrexate—esophageal cancer	0.000289	0.000401	CcSEcCtD
Tramadol—Nausea—Methotrexate—esophageal cancer	0.000274	0.00038	CcSEcCtD
Tramadol—CHRM3—Signaling by GPCR—GHRL—esophageal cancer	0.000104	0.000378	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ANXA1—esophageal cancer	0.000104	0.000377	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PFN1—esophageal cancer	0.000104	0.000376	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—TYMP—esophageal cancer	0.000104	0.000376	CbGpPWpGaD
Tramadol—CHRM3—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000102	0.00037	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000101	0.000367	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CA1—esophageal cancer	0.000101	0.000367	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SST—esophageal cancer	0.000101	0.000367	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP26A1—esophageal cancer	0.000101	0.000366	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NOTCH2—esophageal cancer	0.000101	0.000365	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GAPDH—esophageal cancer	0.000101	0.000365	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—XIAP—esophageal cancer	0.000101	0.000364	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CRABP1—esophageal cancer	9.98e-05	0.000361	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—GHRL—esophageal cancer	9.86e-05	0.000357	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOTCH3—esophageal cancer	9.86e-05	0.000357	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALOX15—esophageal cancer	9.84e-05	0.000356	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HIST1H2BM—esophageal cancer	9.78e-05	0.000354	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—FBXW7—esophageal cancer	9.7e-05	0.000351	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PDE4D—esophageal cancer	9.69e-05	0.000351	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CTNNA1—esophageal cancer	9.51e-05	0.000345	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GNG7—esophageal cancer	9.49e-05	0.000344	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL2—esophageal cancer	9.46e-05	0.000343	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—TPI1—esophageal cancer	9.38e-05	0.00034	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTO1—esophageal cancer	9.38e-05	0.00034	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ELMO1—esophageal cancer	9.33e-05	0.000338	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CA2—esophageal cancer	9.26e-05	0.000335	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GNG7—esophageal cancer	9.22e-05	0.000334	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	9.14e-05	0.000331	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKAP13—esophageal cancer	9.12e-05	0.00033	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALDOB—esophageal cancer	9e-05	0.000326	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFBR2—esophageal cancer	8.95e-05	0.000324	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ALDH2—esophageal cancer	8.89e-05	0.000322	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOTCH2—esophageal cancer	8.84e-05	0.00032	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PSME1—esophageal cancer	8.83e-05	0.00032	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PSME2—esophageal cancer	8.83e-05	0.00032	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ANXA1—esophageal cancer	8.79e-05	0.000319	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GAPDH—esophageal cancer	8.66e-05	0.000314	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—XIAP—esophageal cancer	8.64e-05	0.000313	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ADH7—esophageal cancer	8.61e-05	0.000312	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PLCE1—esophageal cancer	8.61e-05	0.000312	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CRABP1—esophageal cancer	8.58e-05	0.000311	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SST—esophageal cancer	8.55e-05	0.00031	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SMAD4—esophageal cancer	8.47e-05	0.000307	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GSTT1—esophageal cancer	8.46e-05	0.000306	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	8.42e-05	0.000305	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP2A6—esophageal cancer	8.36e-05	0.000303	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	8.34e-05	0.000302	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOTCH3—esophageal cancer	8.33e-05	0.000302	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—GHRL—esophageal cancer	8.33e-05	0.000302	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FBXW7—esophageal cancer	8.2e-05	0.000297	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CTNNA1—esophageal cancer	8.17e-05	0.000296	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GNG7—esophageal cancer	8.16e-05	0.000296	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL2—esophageal cancer	8.12e-05	0.000294	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GNG7—esophageal cancer	7.93e-05	0.000288	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ENO1—esophageal cancer	7.93e-05	0.000287	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS1—esophageal cancer	7.93e-05	0.000287	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFBR2—esophageal cancer	7.85e-05	0.000284	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PSME1—esophageal cancer	7.81e-05	0.000283	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PSME2—esophageal cancer	7.81e-05	0.000283	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—BLVRB—esophageal cancer	7.78e-05	0.000282	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC52A3—esophageal cancer	7.78e-05	0.000282	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ALDH2—esophageal cancer	7.65e-05	0.000277	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PSME2—esophageal cancer	7.58e-05	0.000275	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PSME1—esophageal cancer	7.58e-05	0.000275	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ANXA1—esophageal cancer	7.55e-05	0.000274	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ADH1B—esophageal cancer	7.55e-05	0.000273	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOTCH2—esophageal cancer	7.47e-05	0.000271	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—XIAP—esophageal cancer	7.44e-05	0.000269	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SMAD4—esophageal cancer	7.43e-05	0.000269	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SST—esophageal cancer	7.34e-05	0.000266	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GSTT1—esophageal cancer	7.28e-05	0.000264	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TYMP—esophageal cancer	7.21e-05	0.000261	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP2A6—esophageal cancer	7.19e-05	0.000261	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOTCH3—esophageal cancer	7.16e-05	0.000259	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GHRL—esophageal cancer	7.16e-05	0.000259	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FBXW7—esophageal cancer	7.04e-05	0.000255	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	7.03e-05	0.000255	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP26A1—esophageal cancer	7.02e-05	0.000254	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	6.99e-05	0.000253	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HIF1A—esophageal cancer	6.93e-05	0.000251	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALOX15—esophageal cancer	6.84e-05	0.000248	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS1—esophageal cancer	6.82e-05	0.000247	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ENO1—esophageal cancer	6.82e-05	0.000247	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP1B1—esophageal cancer	6.74e-05	0.000244	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PSME2—esophageal cancer	6.72e-05	0.000243	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PSME1—esophageal cancer	6.72e-05	0.000243	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFBR2—esophageal cancer	6.63e-05	0.00024	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KDR—esophageal cancer	6.63e-05	0.00024	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CA1—esophageal cancer	6.62e-05	0.00024	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC10A2—esophageal cancer	6.62e-05	0.00024	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PSME2—esophageal cancer	6.53e-05	0.000237	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PSME1—esophageal cancer	6.53e-05	0.000237	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTO1—esophageal cancer	6.52e-05	0.000236	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TPI1—esophageal cancer	6.52e-05	0.000236	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	6.5e-05	0.000235	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOTCH2—esophageal cancer	6.42e-05	0.000233	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP19A1—esophageal cancer	6.34e-05	0.00023	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SST—esophageal cancer	6.32e-05	0.000229	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SMAD4—esophageal cancer	6.28e-05	0.000227	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALDOB—esophageal cancer	6.25e-05	0.000227	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NOTCH1—esophageal cancer	6.24e-05	0.000226	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	6.16e-05	0.000223	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GHRL—esophageal cancer	6.16e-05	0.000223	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HIF1A—esophageal cancer	6.08e-05	0.00022	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	6.06e-05	0.00022	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CA2—esophageal cancer	6.05e-05	0.000219	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GAPDH—esophageal cancer	6.02e-05	0.000218	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CRABP1—esophageal cancer	5.97e-05	0.000216	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KDR—esophageal cancer	5.81e-05	0.000211	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP1B1—esophageal cancer	5.8e-05	0.00021	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—HMOX1—esophageal cancer	5.78e-05	0.000209	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFBR2—esophageal cancer	5.69e-05	0.000206	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GNG7—esophageal cancer	5.67e-05	0.000206	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CREBBP—esophageal cancer	5.66e-05	0.000205	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PLCE1—esophageal cancer	5.63e-05	0.000204	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ADH7—esophageal cancer	5.63e-05	0.000204	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—EGFR—esophageal cancer	5.56e-05	0.000202	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ABCB1—esophageal cancer	5.55e-05	0.000201	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	5.53e-05	0.0002	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOTCH1—esophageal cancer	5.47e-05	0.000198	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP19A1—esophageal cancer	5.45e-05	0.000198	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SMAD4—esophageal cancer	5.39e-05	0.000195	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ALDH2—esophageal cancer	5.32e-05	0.000193	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	5.32e-05	0.000193	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HIF1A—esophageal cancer	5.14e-05	0.000186	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NOS3—esophageal cancer	5.07e-05	0.000184	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTT1—esophageal cancer	5.06e-05	0.000183	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP2A6—esophageal cancer	5e-05	0.000181	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—HMOX1—esophageal cancer	4.97e-05	0.00018	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CREBBP—esophageal cancer	4.96e-05	0.00018	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ADH1B—esophageal cancer	4.93e-05	0.000179	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KDR—esophageal cancer	4.91e-05	0.000178	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	4.9e-05	0.000178	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EGFR—esophageal cancer	4.88e-05	0.000177	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—PIK3CA—esophageal cancer	4.83e-05	0.000175	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ABCB1—esophageal cancer	4.77e-05	0.000173	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ERBB2—esophageal cancer	4.74e-05	0.000172	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ENO1—esophageal cancer	4.74e-05	0.000172	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS1—esophageal cancer	4.74e-05	0.000172	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TYMP—esophageal cancer	4.72e-05	0.000171	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PSME2—esophageal cancer	4.67e-05	0.000169	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PSME1—esophageal cancer	4.67e-05	0.000169	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—PIK3CA—esophageal cancer	4.66e-05	0.000169	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	4.64e-05	0.000168	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOTCH1—esophageal cancer	4.63e-05	0.000168	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.59e-05	0.000166	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALOX15—esophageal cancer	4.47e-05	0.000162	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOS3—esophageal cancer	4.44e-05	0.000161	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HIF1A—esophageal cancer	4.41e-05	0.00016	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TPI1—esophageal cancer	4.26e-05	0.000155	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.26e-05	0.000155	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—PIK3CA—esophageal cancer	4.23e-05	0.000153	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KDR—esophageal cancer	4.22e-05	0.000153	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CREBBP—esophageal cancer	4.19e-05	0.000152	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCND1—esophageal cancer	4.19e-05	0.000152	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ERBB2—esophageal cancer	4.16e-05	0.000151	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EGFR—esophageal cancer	4.12e-05	0.000149	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALDOB—esophageal cancer	4.09e-05	0.000148	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CDKN1A—esophageal cancer	4.05e-05	0.000147	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP1B1—esophageal cancer	4.03e-05	0.000146	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOTCH1—esophageal cancer	3.97e-05	0.000144	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	3.94e-05	0.000143	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.94e-05	0.000143	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.9e-05	0.000141	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EP300—esophageal cancer	3.85e-05	0.00014	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	3.8e-05	0.000138	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP19A1—esophageal cancer	3.79e-05	0.000137	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOS3—esophageal cancer	3.76e-05	0.000136	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNG7—esophageal cancer	3.71e-05	0.000134	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CREBBP—esophageal cancer	3.71e-05	0.000134	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—esophageal cancer	3.67e-05	0.000133	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KDR—esophageal cancer	3.63e-05	0.000132	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CREBBP—esophageal cancer	3.6e-05	0.000131	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CA—esophageal cancer	3.58e-05	0.00013	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1A—esophageal cancer	3.55e-05	0.000129	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—esophageal cancer	3.54e-05	0.000128	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ERBB2—esophageal cancer	3.51e-05	0.000127	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.48e-05	0.000126	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HMOX1—esophageal cancer	3.46e-05	0.000125	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	3.42e-05	0.000124	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CA—esophageal cancer	3.38e-05	0.000123	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EP300—esophageal cancer	3.38e-05	0.000122	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—esophageal cancer	3.36e-05	0.000122	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NOS3—esophageal cancer	3.32e-05	0.00012	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ABCB1—esophageal cancer	3.32e-05	0.00012	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.31e-05	0.00012	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—esophageal cancer	3.29e-05	0.000119	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.27e-05	0.000118	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOS3—esophageal cancer	3.23e-05	0.000117	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CREBBP—esophageal cancer	3.19e-05	0.000116	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—esophageal cancer	3.1e-05	0.000112	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	3.1e-05	0.000112	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.1e-05	0.000112	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ENO1—esophageal cancer	3.1e-05	0.000112	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CA—esophageal cancer	3.07e-05	0.000111	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PSME2—esophageal cancer	3.05e-05	0.000111	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PSME1—esophageal cancer	3.05e-05	0.000111	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	3.05e-05	0.00011	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—esophageal cancer	3.04e-05	0.00011	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ERBB2—esophageal cancer	3.02e-05	0.000109	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	3e-05	0.000109	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—esophageal cancer	2.95e-05	0.000107	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	2.91e-05	0.000106	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—esophageal cancer	2.88e-05	0.000104	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EP300—esophageal cancer	2.86e-05	0.000104	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NOS3—esophageal cancer	2.86e-05	0.000104	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CA—esophageal cancer	2.85e-05	0.000103	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOS3—esophageal cancer	2.78e-05	0.000101	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—esophageal cancer	2.76e-05	0.0001	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—esophageal cancer	2.67e-05	9.66e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	2.64e-05	9.58e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.63e-05	9.55e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—esophageal cancer	2.61e-05	9.47e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	2.6e-05	9.41e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1A—esophageal cancer	2.58e-05	9.34e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—EP300—esophageal cancer	2.53e-05	9.15e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CA—esophageal cancer	2.5e-05	9.06e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—esophageal cancer	2.49e-05	9.02e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.48e-05	8.97e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EP300—esophageal cancer	2.45e-05	8.89e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—esophageal cancer	2.43e-05	8.82e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—esophageal cancer	2.42e-05	8.76e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—esophageal cancer	2.29e-05	8.31e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.26e-05	8.19e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	2.22e-05	8.04e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.22e-05	8.04e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—EP300—esophageal cancer	2.17e-05	7.87e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.17e-05	7.86e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—esophageal cancer	2.14e-05	7.75e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	2.11e-05	7.66e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EP300—esophageal cancer	2.11e-05	7.65e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—esophageal cancer	2.09e-05	7.58e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—esophageal cancer	2.04e-05	7.41e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NOS3—esophageal cancer	1.99e-05	7.19e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CA—esophageal cancer	1.87e-05	6.77e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—esophageal cancer	1.84e-05	6.67e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.82e-05	6.58e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CA—esophageal cancer	1.81e-05	6.58e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—esophageal cancer	1.8e-05	6.52e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—esophageal cancer	1.76e-05	6.36e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CA—esophageal cancer	1.61e-05	5.82e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	1.56e-05	5.66e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—esophageal cancer	1.51e-05	5.48e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—EP300—esophageal cancer	1.51e-05	5.47e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.45e-05	5.25e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NOS3—esophageal cancer	1.3e-05	4.7e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.19e-05	4.3e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.12e-05	4.05e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—EP300—esophageal cancer	9.87e-06	3.58e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CA—esophageal cancer	7.3e-06	2.65e-05	CbGpPWpGaD
